ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | +2.4% | 61,973 | +2.7% | 0.00% | – |
| Q2 2023 | $83 | +9.2% | 60,373 | +87.7% | 0.00% | – |
| Q1 2023 | $76 | +11.8% | 32,173 | +8.4% | 0.00% | – |
| Q4 2022 | $68 | -99.9% | 29,673 | -6.9% | 0.00% | – |
| Q3 2022 | $88,000 | +11.4% | 31,873 | -0.9% | 0.00% | – |
| Q2 2022 | $79,000 | +8.2% | 32,173 | +74.2% | 0.00% | – |
| Q1 2022 | $73,000 | +21.7% | 18,473 | +35.1% | 0.00% | – |
| Q4 2021 | $60,000 | -75.5% | 13,673 | -65.5% | 0.00% | – |
| Q3 2021 | $245,000 | +46.7% | 39,663 | +87.9% | 0.00% | – |
| Q2 2021 | $167,000 | -42.2% | 21,107 | -22.0% | 0.00% | – |
| Q1 2021 | $289,000 | – | 27,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |